Biolexis Therapeutics has achieved a transformative milestone in metabolic drug discovery with the successful resolution of ...

In older adults with diabetes, GLP-1 receptor agonists were tied to a slightly lower risk for depression compared with one diabetes drug class but not another, a target emulation trial using Medicare ...

The news has been littered with stories these days about people losing weight using GLP-1 weight loss drugs like Ozempic. Now ...

Vivani Medical, Inc. ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced that it intends to spin off ...

Protein intake requirement may differ for different individuals. Read on to know how proteins or protein supplements affect health. TheHealthSite.com ...

Laekna (2105.HK) announced that the U.S. Food and Drug Administration (FDA) has approved the IND for LAE120, an internally discovered USP1 inhibitor, for the treatment of advanced solid tumors. LAE120 ...

It has a unique chemical structure differentiated from all the ... It also demonstrates good therapeutic windows in GLP long-term toxicology study. Laekna is actively exploring partnerships ...

Genetic Evidence That Diabetes Drug GLP-1 Receptor Agonists Achieve Weight ... Feb. 14, 2025 — The chemical compound sulforaphane found in broccoli sprouts can be linked to improved blood ...

American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an unlikely boomtown.

Q1 2025 Earnings Conference Call February 26, 2025 4:30 PM ETCompany ParticipantsParmeet Ahuja - Vice President ...